Xenon Pharmaceuticals Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Xenon Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Xenon Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$73.7M, a 32.3% decline year-over-year.
  • Xenon Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$256M, a 25.4% decline year-over-year.
  • Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$214M, a 65.8% decline from 2022.
  • Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$129M, a 63.5% decline from 2021.
  • Xenon Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$79M, a 152% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$214M -$84.9M -65.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$129M -$50.2M -63.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$79M -$47.7M -152% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$31.3M +$11.5M +26.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$42.8M -$4.78M -12.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$38M -$5.47M -16.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 -$32.6M -$7.76M -31.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$24.8M -$15.5M -165% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 -$9.36M -$20.5M -184% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $11.1M +$1.39M +14.4% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-08
2013 $9.71M +$12.9M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-08
2012 -$3.15M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.